210 related articles for article (PubMed ID: 20068178)
1. Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells.
García-Olmo DC; Domínguez C; García-Arranz M; Anker P; Stroun M; García-Verdugo JM; García-Olmo D
Cancer Res; 2010 Jan; 70(2):560-7. PubMed ID: 20068178
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic transformation induced by cell-free nucleic acids circulating in plasma (genometastasis) remains after the surgical resection of the primary tumor: a pilot study.
García-Olmo D; García-Olmo DC; Domínguez-Berzosa C; Guadalajara H; Vega L; García-Arranz M
Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S61-8. PubMed ID: 22568822
[TBL] [Abstract][Full Text] [Related]
3. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
4. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
5. Persistence of K-ras mutations in plasma after colorectal tumor resection.
Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
[TBL] [Abstract][Full Text] [Related]
6. NIH-3T3 fibroblasts cultured with plasma from colorectal cancer patients generate poorly differentiated carcinomas in mice.
Serrano-Heras G; Domínguez-Berzosa C; Collantes E; Guadalajara H; García-Olmo D; García-Olmo DC
Cancer Lett; 2012 Mar; 316(1):85-90. PubMed ID: 22093615
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer.
Frattini M; Gallino G; Signoroni S; Balestra D; Lusa L; Battaglia L; Sozzi G; Bertario L; Leo E; Pilotti S; Pierotti MA
Cancer Lett; 2008 May; 263(2):170-81. PubMed ID: 18395974
[TBL] [Abstract][Full Text] [Related]
8. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
10. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors.
Khanna M; Park P; Zirvi M; Cao W; Picon A; Day J; Paty P; Barany F
Oncogene; 1999 Jan; 18(1):27-38. PubMed ID: 9926917
[TBL] [Abstract][Full Text] [Related]
11. [Transformation of NIH/3T3 cells and SW 480 cells displaying K-ras mutation].
Anker P; Lyautey J; Lefort F; Lederrey C; Stroun M
C R Acad Sci III; 1994 Oct; 317(10):869-74. PubMed ID: 7882132
[TBL] [Abstract][Full Text] [Related]
12. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
[TBL] [Abstract][Full Text] [Related]
13. [Identification of the transforming Ha-ras gene in human melanoma, neuroblastoma and breast cancer cells].
Kniazev PG; Schäfer R; Willecke K; Seits IF
Vopr Onkol; 1985; 31(6):77-85. PubMed ID: 4024551
[TBL] [Abstract][Full Text] [Related]
14. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
15. [A study on reversion of the human activated c-Ha-ras-transformed cells].
Ogiso Y
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
[TBL] [Abstract][Full Text] [Related]
16. Evidence against ras activation in human ovarian carcinomas.
Haas M; Isakov J; Howell SB
Mol Biol Med; 1987 Oct; 4(5):265-75. PubMed ID: 3320675
[TBL] [Abstract][Full Text] [Related]
17. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
[TBL] [Abstract][Full Text] [Related]
18. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection.
Su ZZ; Olsson CA; Zimmer SG; Fisher PB
Anticancer Res; 1992; 12(2):297-304. PubMed ID: 1580547
[TBL] [Abstract][Full Text] [Related]
19. Study of oncogenic potentialities of human melanoma: identification of N-ras oncogene after DNA transfer and tumour induction.
Jouanneau J; Bertrand S; Ducros E; Longuet M; Dore JF; Tavitian A
In Vivo; 1987; 1(2):119-24. PubMed ID: 2979772
[TBL] [Abstract][Full Text] [Related]
20. K-ras activation in neoplasms of the human female reproductive tract.
Enomoto T; Inoue M; Perantoni AO; Terakawa N; Tanizawa O; Rice JM
Cancer Res; 1990 Oct; 50(19):6139-45. PubMed ID: 2205377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
